TipRanks
Go Ultimate55% OFF

Xilio Therapeutics (XLO) Cash flow

Xilio Therapeutics Cash Flow

XLO's free cash flow for Q2 2026 was $-18.78M. For the 2026 fiscal year, XLO's free cash flow was decreased by $-19.00K and operating cash flow was $-18.76M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -4.99M$ -18.38M$ -68.62M$ -75.72M$ -80.75M
$ -518.00K$ -36.00K$ -486.00K$ -1.87M$ -1.10M
$ 87.78M$ 29.20M$ -6.55M$ -69.00K$ 260.67M
$ 139.34M$ 57.07M$ 44.70M$ 120.39M$ 199.61M
$ -5.51M$ -18.41M$ -69.11M$ -77.59M$ -81.85M

Currency in USD

Xilio Therapeutics Cash Flow

-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing